{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:23:54Z","timestamp":1780446234211,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00296-018-4210-2","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:36Z","timestamp":1542758436000},"page":"337-344","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Tocilizumab treatment in refractory polyarteritis nodosa: a case report and review of the literature"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0582-7790","authenticated-orcid":false,"given":"Martin","family":"Krusche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8394-969X","authenticated-orcid":false,"given":"Nikolas","family":"Ruffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9262-005X","authenticated-orcid":false,"given":"Ina","family":"K\u00f6tter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,21]]},"reference":[{"issue":"1","key":"4210_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65(1):1\u201311. \n                    https:\/\/doi.org\/10.1002\/art.37715","journal-title":"Arthritis Rheum"},{"issue":"6","key":"4210_CR2","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.autrev.2016.02.015","volume":"15","author":"A Virgilio De","year":"2016","unstructured":"De Virgilio A, Greco A, Magliulo G, Gallo A, Ruoppolo G, Conte M, Martellucci S, de Vincentiis M (2016) Polyarteritis nodosa: a contemporary overview. Autoimmun Rev 15(6):564\u2013570. \n                    https:\/\/doi.org\/10.1016\/j.autrev.2016.02.015","journal-title":"Autoimmun Rev"},{"issue":"2","key":"4210_CR3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s12016-017-8643-2","volume":"54","author":"F Muratore","year":"2018","unstructured":"Muratore F, Pazzola G, Soriano A, Pipitone N, Croci S, Bonacini M, Boiardi L, Salvarani C (2018) Unmet needs in the pathogenesis and treatment of vasculitides. Clin Rev Allergy Immunol 54(2):244\u2013260. \n                    https:\/\/doi.org\/10.1007\/s12016-017-8643-2","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"4210_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.intimp.2015.03.020","volume":"27","author":"J Loricera","year":"2015","unstructured":"Loricera J, Blanco R, Hernandez JL, Pina T, Gonzalez-Vela MC, Gonzalez-Gay MA (2015) Biologic therapy in ANCA-negative vasculitis. Int Immunopharmacol 27(2):213\u2013219. \n                    https:\/\/doi.org\/10.1016\/j.intimp.2015.03.020","journal-title":"Int Immunopharmacol"},{"issue":"25","key":"4210_CR5","doi-asserted-by":"publisher","first-page":"e11053","DOI":"10.1097\/MD.0000000000011053","volume":"97","author":"CR Wang","year":"2018","unstructured":"Wang CR, Yang CC (2018) Adalimumab therapy in hepatitis B virus-negative polyarteritis nodosa: a case report. Medicine (Baltimore) 97(25):e11053. \n                    https:\/\/doi.org\/10.1097\/MD.0000000000011053","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"4210_CR6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.it.2012.07.003","volume":"33","author":"M Rincon","year":"2012","unstructured":"Rincon M (2012) Interleukin-6: from an inflammatory marker to a target for inflammatory diseases. Trends Immunol 33(11):571\u2013577. \n                    https:\/\/doi.org\/10.1016\/j.it.2012.07.003","journal-title":"Trends Immunol"},{"issue":"1","key":"4210_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/TP.0000000000001452","volume":"101","author":"SC Jordan","year":"2017","unstructured":"Jordan SC, Choi J, Kim I, Wu G, Toyoda M, Shin B, Vo A (2017) Interleukin-6, a cytokine critical to mediation of inflammation, autoimmunity and allograft rejection: therapeutic implications of IL-6 receptor blockade. Transplantation 101(1):32\u201344. \n                    https:\/\/doi.org\/10.1097\/TP.0000000000001452","journal-title":"Transplantation"},{"issue":"6","key":"4210_CR8","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1177\/000331979204300610","volume":"43","author":"H Nakahama","year":"1992","unstructured":"Nakahama H, Okada M, Miyazaki M, Imai N, Yokokawa T, Kubori S (1992) Distinct responses of interleukin-6 and other laboratory parameters to treatment in a patient with polyarteritis nodosa\u2014a case report. Angiology 43(6):512\u2013516. \n                    https:\/\/doi.org\/10.1177\/000331979204300610","journal-title":"Angiology"},{"issue":"1","key":"4210_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3109\/14397595.2013.852840","volume":"24","author":"Y Horai","year":"2014","unstructured":"Horai Y, Tokuyama A, Sumiyoshi R, Nakashima Y, Suzuki T, Okada A, Kawashiri SY, Ichinose K, Izumi Y, Miyashita T, Tamai M, Yamasaki S, Nakamura H, Hayashi T, Origuchi T, Kawakami A (2014) A case of cutaneous polyarteritis nodosa with elevated serum interleukin-6 levels complicated by leg arterial stenosis and destructive arthropathy of the left ankle. Mod Rheumatol 24(1):206\u2013211. \n                    https:\/\/doi.org\/10.3109\/14397595.2013.852840","journal-title":"Mod Rheumatol"},{"issue":"3","key":"4210_CR10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.2340\/00015555-1228","volume":"92","author":"T Kawakami","year":"2012","unstructured":"Kawakami T, Takeuchi S, Soma Y (2012) Serum levels of interleukin-6 in patients with cutaneous polyarteritis nodosa. Acta Derm Venereol 92(3):322\u2013323. \n                    https:\/\/doi.org\/10.2340\/00015555-1228","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"4210_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/BOR.0b013e3283456797","volume":"23","author":"M Murakami","year":"2011","unstructured":"Murakami M, Nishimoto N (2011) The value of blocking IL-6 outside of rheumatoid arthritis: current perspective. Curr Opin Rheumatol 23(3):273\u2013277. \n                    https:\/\/doi.org\/10.1097\/BOR.0b013e3283456797","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"4210_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1613849","volume":"377","author":"JH Stone","year":"2017","unstructured":"Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Schett G, Schulze-Koops H, Spiera R, Unizony SH, Collinson N (2017) Trial of tocilizumab in giant-cell arteritis. N Engl J Med 377(4):317\u2013328. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1613849","journal-title":"N Engl J Med"},{"issue":"3","key":"4210_CR13","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/annrheumdis-2017-211878","volume":"77","author":"Y Nakaoka","year":"2018","unstructured":"Nakaoka Y, Isobe M, Takei S, Tanaka Y, Ishii T, Yokota S, Nomura A, Yoshida S, Nishimoto N (2018) Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study). Ann Rheum Dis 77(3):348\u2013354. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2017-211878","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"4210_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3109\/13506129.2013.838947","volume":"20","author":"A Ho\u010devar","year":"2013","unstructured":"Ho\u010devar A, Lestan B, Semrl SS, Lakota K, Kojc N, Potocnik N, Tomsic M (2013) AA amyloidosis in a polyarteritis nodosa patient treated with tocilizumab. Amyloid 20(4):275\u2013276. \n                    https:\/\/doi.org\/10.3109\/13506129.2013.838947","journal-title":"Amyloid"},{"key":"4210_CR15","doi-asserted-by":"publisher","first-page":"7987081","DOI":"10.1155\/2016\/7987081","volume":"2016","author":"K Watanabe","year":"2016","unstructured":"Watanabe K, Rajderkar DA, Modica RF (2016) A case of polyarteritis nodosa associated with vertebral artery vasculitis treated successfully with tocilizumab and cyclophosphamide. Case Rep Pediatr 2016:7987081. \n                    https:\/\/doi.org\/10.1155\/2016\/7987081","journal-title":"Case Rep Pediatr"},{"issue":"4","key":"4210_CR16","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1080\/13506129.2016.1232648","volume":"23","author":"J Ostrovr\u0161nik","year":"2016","unstructured":"Ostrovr\u0161nik J, Ho\u010devar A, Lestan B, Sodin Semrl S, Lakota K, Tomsic M (2016) Long-term follow-up on tocilizumab treatment of AA amyloidosis secondary to polyarteritis nodosa. Amyloid 23(4):260\u2013261. \n                    https:\/\/doi.org\/10.1080\/13506129.2016.1232648","journal-title":"Amyloid"},{"issue":"1","key":"4210_CR17","doi-asserted-by":"publisher","first-page":"e000446","DOI":"10.1136\/rmdopen-2017-000446","volume":"3","author":"A Saunier","year":"2017","unstructured":"Saunier A, Issa N, Vandenhende MA, Morlat P, Doutre MS, Bonnet F (2017) Treatment of polyarteritis nodosa with tocilizumab: a new therapeutic approach? RMD Open 3(1):e000446. \n                    https:\/\/doi.org\/10.1136\/rmdopen-2017-000446","journal-title":"RMD Open"},{"key":"4210_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jaut.2014.01.029","volume":"48\u201349","author":"J Hernandez-Rodriguez","year":"2014","unstructured":"Hernandez-Rodriguez J, Alba MA, Prieto-Gonzalez S, Cid MC (2014) Diagnosis and classification of polyarteritis nodosa. J Autoimmun 48\u201349:84\u201389. \n                    https:\/\/doi.org\/10.1016\/j.jaut.2014.01.029","journal-title":"J Autoimmun"},{"issue":"10","key":"4210_CR19","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJMoa1307362","volume":"370","author":"P Navon Elkan","year":"2014","unstructured":"Navon Elkan P, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, Zlotogorski A, Berkun Y, Press JJ, Mukamel M, Voth I, Hashkes PJ, Harel L, Hoffer V, Ling E, Yalcinkaya F, Kasapcopur O, Lee MK, Klevit RE, Renbaum P, Weinberg-Shukron A, Sener EF, Schormair B, Zeligson S, Marek-Yagel D, Strom TM, Shohat M, Singer A, Rubinow A, Pras E, Winkelmann J, Tekin M, Anikster Y, King MC, Levy-Lahad E (2014) Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med 370(10):921\u2013931. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1307362","journal-title":"N Engl J Med"},{"issue":"19","key":"4210_CR20","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMc1709609","volume":"377","author":"T Nozawa","year":"2017","unstructured":"Nozawa T, Imagawa T, Ito S (2017) Coronary-artery aneurysm in tocilizumab-treated children with Kawasaki\u2019s disease. N Engl J Med 377(19):1894\u20131896. \n                    https:\/\/doi.org\/10.1056\/NEJMc1709609","journal-title":"N Engl J Med"},{"issue":"7586","key":"4210_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature17039","volume":"529","author":"M Karin","year":"2016","unstructured":"Karin M, Clevers H (2016) Reparative inflammation takes charge of tissue regeneration. Nature 529(7586):307\u2013315. \n                    https:\/\/doi.org\/10.1038\/nature17039","journal-title":"Nature"},{"issue":"5","key":"4210_CR22","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2013.08.1667","volume":"65","author":"U Ebersberger","year":"2015","unstructured":"Ebersberger U, Rieber J, Wellmann P, Goebel C, Gansera B (2015) Polyarteritis nodosa causing a vast coronary artery aneurysm. J Am Coll Cardiol 65(5):e1\u2013e2. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2013.08.1667","journal-title":"J Am Coll Cardiol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-018-4210-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4210-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4210-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T19:13:44Z","timestamp":1574277224000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-018-4210-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,21]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["4210"],"URL":"https:\/\/doi.org\/10.1007\/s00296-018-4210-2","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,21]]},"assertion":[{"value":"27 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Martin Krusche reports receiving financial support from Chugai for an educational program and honorarium for a talk. Nikolas Ruffer declares that he has no conflict of interest. Ina K\u00f6tter reports receiving honorarium from Chugai and Roche for talks.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. All authors fulfilled the ICMJE authorship criteria.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the individual participant included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}